Clinical Trial Update: Buspirone in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for buspirone in Parkinson's disease and anxiety has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Parkinson Disease

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: University of Rochester | Conditions: Parkinson Disease, Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2020-01-02